ALMAC Group

Partnering to Advance Human Health

A unique culture delivering exceptional solutions: Almac is a financially secure, privately owned organisation with 7,800+ employees globally. 600+ companies worldwide, including all the market leaders, use our services, testament itself to the quality, innovation and efficiency of our business as proven over the past 55+ years.

Our vast range of services include:

Biomarker Discovery & Development: Pre-clinical biomarker discovery, through to full companion diagnostic development and clinical test delivery from our CLIA lab.

API Services & Chemical Development: Services for all stages of drug development for small molecules, potent and cytotoxic compounds and peptides.

Pharmaceutical Development: Developing clinical candidates into an optimum formulation and manufacturing drug product for all phases of clinical trial supply.

Analytical Services: Delivering comprehensive solutions supporting drug substance and product development programmes.

Clinical Trial Supply: Comprehensive global clinical supply chain solutions providing physical resources and supportive technologies ensuring your clinical supply chain continually delivers across the globe.

Clinical Technologies: Providing randomisation and trial supply management technology, electronic Clinical Outcome Assessments (eCOA), patient alerts and reminders, data integration and biostatistical consulting services.

Commercial Services: Providing commercial manufacturing and packaging solutions and supporting commercial product launch.

Find out about our exceptional career opportunities: http://www.almacgroup.com/careers and join our talent network https://www.almacgroup.com/careers/talent-network/

Beware of recruitment scams online: https://www.almacgroup.com/beware-of-recruitment-scams/